Sensitivity and specificity of GPC-1 detection for prostate cancer in cell sediments from patient urine samples using MIL-38: Comparison of prostate cancer samples with BPH and normal samples.

<p>Sensitivity and specificity of GPC-1 detection for prostate cancer in cell sediments from patient urine samples using MIL-38: Comparison of prostate cancer samples with BPH and normal samples.</p

Patient demographics and clinical characteristics.

<p>Patient demographics and clinical characteristics.</p

Logistic regression odds ratios for a positive MIL-38 IFA result adjusted for patient PSA value.

<p>Logistic regression odds ratios for a positive MIL-38 IFA result adjusted for patient PSA value.</p

Selected characteristics of cases and controls, by race, in the Kidney Cancer Study, 2002–2007.

<p>Abbreviation: H.S. = high school.</p

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the Seer-Medicare Database

<p><b>Article full text</b></p><p><br></p><p>The full text of this article can be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s12325-018-0738-5">https://link.springer.com/article/10.1007/s12325-018-0738-5</a></p><p></p><p><br></p><p><b>Provide enhanced content for this article</b></p><p><br></p><p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/”mailto:[email protected]”"><b>[email protected]</b></a>.</p><p><br></p><p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p><p><br></p><p>Other enhanced features include, but are not limited to:</p><p><br></p><p>• Slide decks</p><p>• Videos and animations</p><p>• Audio abstracts</p><p> </p><p>• Audio slides</p> <p><b> </b></p

Association between blood mitochondrial DNA (mtDNA) copy number and renal cell carcinoma risk (overall and stratified by sex and race) in the Kidney Cancer Study, 2002–2007.

<p>Abbreviations: mtDNA = mitochondrial DNA; N_Ca = number of cases; N_Co = number of controls; OR = odds ratio; CI = confidence interval; SD = standard deviation; Q1 = quartile 1; Q2 = quartile 2; Q3 = quartile 3; Q4 = quartile 4.</p>1<p>Odds ratio computed from unconditional logistic regression models adjusted for study center, age group, sex (except for sex-specific models), race (except for race-specific models), education level, BMI, smoking status, and history of hypertension.</p>2<p>Standard deviation = 0.27.</p>3<p>Quartile 1 split into two subcategories using intra-quartile median (i.e., twelfth-and-a-half percentile) among controls as cutpoint.</p